| 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 3,0 M € | -3.5% | 3,1 M € | +15.4% | 2,7 M € | +396.4% | 545,9 k € | +17.6% | 464,1 k € | -24.9% | 618,0 k € | +63.8% | 377,3 k € | +15.8% | 325,9 k € | +4.5% | 311,8 k € | -1.2% | 315,6 k € | +28.4% | 245,8 k € | +3.7% | 237,1 k € | ||
| Gross margin | 1,2 M € | — | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||
| EBITDA | 83,2 k € | -22.9% | 107,9 k € | +75.1% | 61,6 k € | -61.2% | 159,0 k € | +35.9% | 117,0 k € | +62.4% | 72,0 k € | -56.7% | 166,2 k € | +849.2% | 17,5 k € | -74.3% | 68,0 k € | +901.2% | 6,8 k € | +111.5% | -59,2 k € | +57.3% | -138,5 k € | -2930.3% | 4,9 k € | |
| Operating profit | 96,2 k € | -2.6% | 98,8 k € | +65.8% | 59,6 k € | -57.7% | 140,8 k € | +20.4% | 117,0 k € | +62.4% | 72,0 k € | -56.6% | 166,0 k € | +876.0% | 17,0 k € | -74.8% | 67,5 k € | +939.7% | 6,5 k € | +111.0% | -59,2 k € | +57.3% | -138,5 k € | -2930.3% | 4,9 k € | |
| Profit/loss | 103,9 k € | +12.2% | 92,6 k € | +58.2% | 58,5 k € | -40.4% | 98,3 k € | +97.7% | 49,7 k € | +110.9% | 23,6 k € | -55.0% | 52,4 k € | +1538.9% | 3,2 k € | -98.6% | 223,7 k € | +4914.1% | -4,6 k € | +92.2% | -59,8 k € | +56.9% | -138,7 k € | -6396.8% | 2,2 k € | |
| Equity | 1,0 M € | +11.4% | 912,7 k € | +11.3% | 820,1 k € | +7.7% | 761,5 k € | +347.6% | 170,1 k € | +41.3% | 120,4 k € | +24.3% | 96,9 k € | +117.7% | 44,5 k € | +7.7% | 41,3 k € | +122.6% | -182,4 k € | -2.6% | -177,7 k € | -50.7% | -117,9 k € | -666.8% | 20,8 k € | |
| Total assets | 1,9 M € | +8.1% | 1,7 M € | +13.7% | 1,5 M € | +20.5% | 1,3 M € | +206.4% | 416,5 k € | +74.1% | 239,2 k € | -22.4% | 308,2 k € | +173.2% | 112,8 k € | -21.5% | 143,7 k € | +81.3% | 79,3 k € | +132.0% | 34,2 k € | -69.7% | 112,8 k € | +11.7% | 101,0 k € | |
| Cash | 178,7 k € | -56.4% | 409,7 k € | +4.3% | 392,9 k € | -21.1% | 498,2 k € | +381.9% | 103,4 k € | +138.5% | 43,4 k € | -40.0% | 72,3 k € | +101.0% | 36,0 k € | -10.0% | 40,0 k € | -43.7% | 71,0 k € | +163.7% | 26,9 k € | -11.8% | 30,5 k € | -51.5% | 63,0 k € | |
| Debts | 547,7 k € | +26.1% | 434,3 k € | +10.2% | 394,0 k € | +38.0% | 285,5 k € | +15.9% | 246,3 k € | +107.5% | 118,7 k € | -43.8% | 211,3 k € | +250.8% | 60,2 k € | -41.2% | 102,4 k € | -60.8% | 261,7 k € | +23.5% | 211,9 k € | -8.1% | 230,6 k € | +187.8% | 80,1 k € | |
| Staff | 6,5 | 5,1 | 4 | 4 | 2 | 1,7 | 2 | 1,9 | 1 | 1,5 | 2,1 | 2,2 | 1 | |||||||||||||
Private limited company · Antwerpen · incorporated on 01/02/2007 · 6,5 ETP
Private limited company profitable and well capitalised. Cash position declining (-56.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Sakura Finetek Belgium is a Private limited company incorporated in 2007. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Antwerpen. It employs on average 6,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette